home / stock / cdmop / cdmop quote
Last: | $25.0602 |
---|---|
Change Percent: | 0.0% |
Open: | $25.07 |
Close: | $25.0602 |
High: | $25.07 |
Low: | $25.04 |
Volume: | 12,466 |
Last Trade Date Time: | 04/12/2021 04:57:03 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$25.0602 | $25.07 | $25.0602 | $25.07 | $25.04 | 12,466 | 04-12-2021 |
$25.06 | $25.0698 | $25.06 | $25.07 | $25.05 | 3,990 | 04-09-2021 |
$25.0578 | $25.05 | $25.0578 | $25.0578 | $25.04 | 12,654 | 04-08-2021 |
$25.07 | $25.04 | $25.07 | $25.07 | $25.04 | 19,791 | 04-07-2021 |
$25.0499 | $25.05 | $25.0499 | $25.05 | $25.04 | 22,328 | 04-06-2021 |
$25.0499 | $25.04 | $25.0499 | $25.05 | $25.04 | 32,918 | 04-05-2021 |
$25.045 | $25.03 | $25.045 | $25.055 | $25.03 | 17,068 | 04-02-2021 |
$25.045 | $25.03 | $25.045 | $25.055 | $25.03 | 17,068 | 04-01-2021 |
$25.03 | $25.02 | $25.03 | $25.08 | $25.02 | 15,471 | 03-31-2021 |
$25.08 | $25.08 | $25.08 | $25.09 | $25.01 | 23,987 | 03-30-2021 |
$25.089 | $25.08 | $25.089 | $25.15 | $25.04 | 31,311 | 03-29-2021 |
$25.17 | $25.25 | $25.17 | $25.29 | $25.16 | 8,428 | 03-26-2021 |
$25.35 | $25.42 | $25.35 | $25.45 | $25.34 | 9,108 | 03-25-2021 |
$25.35 | $25.3402 | $25.35 | $25.4 | $25.34 | 2,968 | 03-24-2021 |
$25.2 | $25.38 | $25.2 | $25.5 | $25.13 | 26,308 | 03-23-2021 |
$25.3707 | $25.46 | $25.3707 | $25.46 | $25.25 | 8,095 | 03-22-2021 |
$25.336 | $25.3 | $25.336 | $25.44 | $25.3 | 8,848 | 03-19-2021 |
$25.3 | $25.21 | $25.3 | $25.5 | $25.2 | 9,664 | 03-18-2021 |
$25.19 | $25.15 | $25.19 | $25.27 | $25.11 | 4,388 | 03-17-2021 |
$25.28 | $25.49 | $25.28 | $25.49 | $25.11 | 37,043 | 03-16-2021 |
News, Short Squeeze, Breakout and More Instantly...
Avid Bioservices Inc. 10.50% Series E Convertible Preferred Stock Company Name:
CDMOP Stock Symbol:
NASDAQ Market:
-- Recorded Third Quarter Revenue of $33.8 Million -- -- Signed $41 Million in Net New Business Resulting in Record High Backlog of $206 Million -- -- Celebrated Completion of Recent Expansion Program with Grand Opening of Cell and Gene Therapy Manufacturing Facility in January 20...
TUSTIN, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (Nasdaq:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO), announced today it received a notice (the “Notice”) on March 19, 2024 from the Listing Qualificat...
TUSTIN, Calif., March 06, 2024 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufact...